ESPEN guidelines on chronic intestinal failure in adults

L Pironi, J Arends, F Bozzetti, C Cuerda, L Gillanders… - Clinical nutrition, 2016 - Elsevier
Summary Background & aims Chronic Intestinal Failure (CIF) is the long-lasting reduction of
gut function, below the minimum necessary for the absorption of macronutrients and/or water …

ESPEN guideline on chronic intestinal failure in adults–Update 2023

L Pironi, C Cuerda, PB Jeppesen, F Joly, C Jonkers… - Clinical Nutrition, 2023 - Elsevier
Background & aims In 2016, ESPEN published the guideline for Chronic Intestinal Failure
(CIF) in adults. An updated version of ESPEN guidelines on CIF due to benign disease in …

Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta …

A Sanz-Paris, P Matia-Martin, A Martin-Palmero… - Clinical Nutrition, 2020 - Elsevier
Objective The aim of this study was to compare the metabolic benefits of diabetes-specific
formulas (DSF) high in monounsaturated fatty acids (MUFA) with standard formulas (STDF) …

The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition

KC Vennard, DJ Selen, MP Gilbert - Endocrine Practice, 2018 - Elsevier
Objective: Hyperglycemia is a common problem in hospitalized patients receiving artificial
nutrition, and this development of hyperglycemia during parenteral nutrition therapy (PNT) …

ESPEN practical guideline: clinical nutrition in chronic intestinal failure

C Cuerda, L Pironi, J Arends, F Bozzetti, L Gillanders… - Clinical Nutrition, 2021 - Elsevier
Background This practical guideline is based on the ESPEN Guidelines on Chronic
Intestinal Failure in Adults. Methodology ESPEN guidelines have been shortened and …

[HTML][HTML] Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial …

G Olveira, J Abuín, R López, S Herranz… - Clinical Nutrition, 2020 - Elsevier
Background There is no established insulin regimen in T2DM patients receiving parenteral
nutrition. Aims To compare the effectiveness (metabolic control) and safety of two insulin …

Glargine insulin use versus continuous regular insulin in diabetic surgical noncritically ill patients receiving parenteral nutrition: randomized controlled study

HA Hakeam, HA Mulia, A Azzam… - Journal of Parenteral …, 2017 - Wiley Online Library
Background: Hyperglycemia is a major complication of parenteral nutrition (PN). Guidelines
for hyperglycemia management in noncritically ill patients cite basal insulin administration …

Prevalence of diabetes, prediabetes, and stress hyperglycemia: insulin therapy and metabolic control in patients on total parenteral nutrition (prospective multicenter …

G Olveira, MJ Tapia, J Ocón, C Cabrejas-Gómez… - Endocrine Practice, 2015 - Elsevier
Objective The prevalence of carbohydrate metabolism disorders in patients who receive
total parenteral nutrition (TPN) is not well known. These disorders can affect the treatment …

Effects of silibinin on apoptosis and insulin secretion in rat RINm5F pancreatic β-cells

M Mazraesefidi, M Mahmoodi… - Biotechnic & …, 2023 - Taylor & Francis
We investigated whether silibinin, a flavonoid, might be useful for treating diabetes mellitus
by treating five groups of rat RINm5F β-insulinemia cells as follows: control streptozotocin …

Glycemic management of hospitalized patients receiving nutrition support

P Polavarapu, S Pachigolla, A Drincic - Diabetes Spectrum, 2022 - Am Diabetes Assoc
Enteral nutrition (EN) and parenteral nutrition (PN) increase the risk of hyperglycemia and
adverse outcomes, including mortality, in patients with and without diabetes. A blood …